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Memory functions decline with age, and severely deterio-
rate during Alzheimer’s disease (AD). Several studies sug-
gest that dietary/environmental factors can reduce the
prevalence of AD in humans. Magnesium is essential for
maintaining normal body and brain functions. Here we
show that increasing brain magnesium, using a newly
developed magnesium compound (magnesium-L-threo-
nate, MgT), prevents cognitive deficits and pathological
changes in transgenic mice co-expressing familial AD-
linked APP and PS1 variants that mimics the pathological
and behavioral changes of human AD (AD mice). In intact
mice, brain Mg content was found to be the lowest among
all tissues tested; long-term MgT-treatment significantly
elevated Mg levels in brain, and was associated with mark-
edly improved cognitive function. In AD mice, learning and
memory abilities are seriously impaired by 7 months, and
completely deteriorate at 15 months. Strikingly, MgT-treat-
ment was effective in preventing such severe learning and
memory deterioration during the entire course of AD pro-
gression. At the cellular level, MgT-treatment reduced
amyloid deposition in hippocampus and frontal cortex, and
prevented synapse loss in the dentate gyrus (DG) and CA1
areas. The degree of memory improvement was strongly
correlated with the protection of synapse loss, but did not
correlate with the reduction of Ab plaque. Thus, increased
brain Mg might block Ab-induced synaptic dysfunction.
Since AD patients already have Mg deficiency, increase in
brain Mg may represent a new strategy for prevention and
amelioration of AD.
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